Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification
Expands Global Access to Exceptional Quality Diagnostic-like CT Images for Medical Care Teams Using the Radixact System
SUNNYVALE, Calif., June 10, 2021 /PRNewswire/ -- Accuray Inc. (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT™ helical fan-beam kVCT imaging capability. The Accuray-only ClearRT technology is now available to customers in the European Union, United States and Japan, as well as other areas in the world where either the CE Mark or FDA 510(k) clearance are required for commercial distribution.
The Radixact® System, based on the TomoTherapy® platform, with ClearRT imaging provides an integrated 360-degree, helical radiation delivery and imaging system that expands the versatility and performance of image-guided stereotactic body radiation therapy (SBRT) and intensity-modulated radiation treatments (IG-IMRT). The high-fidelity ClearRT imaging solution offers the widest and longest field of view enabling clinicians to see more, know more and do more, offering a new level of precision and accuracy in the treatment of almost any indication that would benefit from radiation therapy.
"The use of SBRT is growing rapidly, offering patients an important option for treating tumors in fewer visits than with conventionally fractionated radiotherapy. This is a major benefit for the patient, but requires technology that can deliver the radiation dose with extreme accuracy and precision. ClearRT was designed to provide a major leap forward in delivering on this prerequisite," said Suzanne Winter, chief commercial officer and senior vice president, R&D at Accuray. "The combination of ClearRT diagnostic-like CT fan-beam imaging with Synchrony®, advanced technology that adapts treatment delivery to tumor motion in real time, provides an unprecedented set of tools for delivering SBRT and IG-IMRT treatments personalized to the unique needs of each patient. This most recent regulatory approval expands access to ClearRT, increasing the number of patients who can benefit from precise and accurate radiation treatments."
Excellent Images From the Start
Learn more about ClearRT here.
Important Safety Information
Safe Harbor Statement
Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.
View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-expands-commercialization-of-clearrt-helical-fan-beam-kvct-imaging-for-the-radixact-system-with-ce-mark-certification-301309784.html
SOURCE Accuray Incorporated
Company Codes: NASDAQ-NMS:ARAY